$1 - $1.25
I’d like to think a market cap of approximately $300m is low ball if they achieve just 2 of their stated ambitions.
3rd party funding of immunotherapies
Cash flow positive
$2 plus if they partner up re TAVR
Add 50% if it were a company the caliber of J&J with an upfront fee.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.86 |
Change
0.060(1.25%) |
Mkt cap ! $75.35M | |||
| Open | High | Low | Value | Volume |
| $4.96 | $4.96 | $4.86 | $17.88K | 3.628K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1026 | $4.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.00 | 800 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |